Publications by authors named "Dave Yeung"

Article Synopsis
  • Cleaved high-molecular-weight kininogen (HKa) serves as a biomarker for the activation of the kallikrein-kinin system (KKS) in patients with hereditary angioedema due to C1 inhibitor deficiency (HAE-C1INH).
  • The study aimed to create an HKa-specific enzyme-linked immunosorbent assay (ELISA) for monitoring KKS activation in the blood of HAE-C1INH patients, utilizing a specific antibody found through phage display.
  • Results showed that HKa levels were significantly higher in HAE-C1INH patients during attacks compared to healthy controls, indicating the potential of this ELISA for advancing drug development and understanding related diseases.
View Article and Find Full Text PDF

Background & Aims: Acute-on-chronic liver failure (ACLF) is characterised by organ failure(s), high short-term mortality, and, pathophysiologically, deranged inflammatory responses. The extracellular matrix (ECM) is critically involved in regulating the inflammatory response. This study aimed to determine alterations in biomarkers of ECM turnover in ACLF and their association with inflammation, organ failures, and mortality.

View Article and Find Full Text PDF

Insufficient drug tolerance presents a major challenge in the development of neutralizing antibody (NAb) assays for biotherapeutics. Sample pre-treatment using solid-phase extraction with acid dissociation (SPEAD) is widely reported to improve drug tolerance. In this paper, a case study is presented in which SPEAD was used in conjunction with a competitive ligand binding NAb assay format.

View Article and Find Full Text PDF

Immunogenicity assessments in response to drug treatment are commonly performed using a tiered approach strategy. All samples are initially tested in a screening assay followed by the evaluation of the screened positive samples in a confirmatory assay. Percent inhibition of signal intensity by the competing unlabeled drug in a confirmatory assay is typically used to measure the specificity of antidrug binding activity in samples, and has been successfully applied to most immunogenicity assays.

View Article and Find Full Text PDF

Recently, we have reported the dysregulation of circulating serotonin (5-hydroxytryptamine, 5-HT) homeostasis in patients with chronic obstructive pulmonary disease (COPD). An increase in metabolism of 5-HT has been reported to induce oxidative stress via monoamine oxidase (MAO)-dependent pathway. The present study aimed at investigating the effect of cigarette smoke exposure on the systemic circulation and local airway 5-HT levels as well as MAO-mediated oxidative pathway using a cigarette smoke-exposed rat model.

View Article and Find Full Text PDF

Humanized monoclonal antibody therapeutics are in many ways indistinguishable from the anti-therapeutic/anti-drug antibodies generated in humans. Therefore, immunogenicity assessments to such therapeutics pose unique challenges in clinical trials especially when significant drug interference is encountered. There are several technology platforms based on the bridging immunogenicity assay format, which have been successfully used for detection and quantification of anti-drug antibodies (ADA) in serum or plasma samples.

View Article and Find Full Text PDF